Author at Microdose

Milee Chang

As a wide-eyed, brainwashed Christian, I thought I could change the world. I was mostly fattening up the wallets of middle-aged, maniacal Korean men with a penchant for power. From born-again Christian, wading through life as an apostate in my 30s, to re-discovering spirituality through drugs, I am figuring my life out before my savings run out. I am an ordinary person who experienced the extraordinary through psychedelic medicine.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Culture

29 Oct 2022

Psychedelic Therapy and the Wabi Sabi Way

Psychedelic therapy can offer alternatives for mental health for people from a variety of backgrounds and cultures...

By Milee Chang

Culture

9 Sep 2022

Rising Spirit: Sisters in Psychedelics

While we wait for our government to catch up, there are those who lead the way, namely two avant-garde psychonauts within the Asian community....

By Milee Chang

Culture

6 Aug 2022

Plant Medicine Changed My Life: Overcoming Stigmas & Cultural Barriers

Plant medicine opened a door for me....

By Milee Chang

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

Latest News

You Might Also Like

9 Feb 2026

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

For much of the last decade, psychedelic medicine has been driven by clinical outcomes first and mechanistic explanations second. Promising results in depression, anxiety, and trauma propelled compounds like psilocybin...

By Madison Roberts

19 Jan 2026

Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative

An industry wide look at how neuroplastogens are reshaping psychedelic medicine in 2026, with insights on Delix, AbbVie’s Gilgamesh acquisition, Enveric, and the shift toward nonhallucinogenic brain therapeutics....

By Madison Roberts

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

As a wide-eyed, brainwashed Christian, I thought I could change the world. I was mostly fattening up the wallets of middle-aged, maniacal Korean men with a penchant for power. From born-again Christian, wading through life as an apostate in my 30s, to re-discovering spirituality through drugs, I am figuring my life out before my savings run out. I am an ordinary person who experienced the extraordinary through psychedelic medicine.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

WordPress Ads